The DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.
The role of STATs in transcriptional control and their impact on cellular function
Abstract
The STAT proteins (Signal Transducers and Activators of Transcription), were identified in the last decade as transcription factors which were critical in mediating virtually all cytokine driven signaling. These proteins are latent in the cytoplasm and become activated through tyrosine phosphorylation which typically occurs through cytokine receptor associated kinases (JAKs) or growth factor receptor tyrosine kinases. Recently a number of non-receptor tyrosine kinases (for example src and abl) have been found to cause STAT phosphorylation. Phosphorylated STATs form homo- or hetero-dimers, enter the nucleus and working coordinately with other transcriptional co-activators or transcription factors lead to increased transcriptional initiation. In normal cells and in animals, ligand dependent activation of the STATs is a transient process, lasting for several minutes to several hours. In contrast, in many cancerous cell lines and tumors, where growth factor dysregulation is frequently at the heart of cellular transformation, the STAT proteins (in particular Stats 1, 3 and 5) are persistently tyrosine phosphorylated or activated. The importance of STAT activation to growth control in experiments using anti-sense molecules or dominant negative STAT protein encoding constructs performed in cell lines or studies in animals lacking specific STATs strongly indicate that STATs play an important role in controlling cell cycle progression and apoptosis. Stat1 plays an important role in growth arrest, in promoting apoptosis and is implicated as a tumor suppressor; while Stats 3 and 5 are involved in promoting cell cycle progression and cellular transformation and preventing apoptosis. Many questions remain including: (1) a better understanding of how the STAT proteins through association with other factors increase transcription initiation; (2) a more complete definition of the sets of genes which are activated by different STATs and (3) how these sets of activated genes differ as a function of cell type. Finally, in the context of many cancers, where STATs are frequently persistently activated, an understanding of the mechanisms leading to their constitutive activation and defining the potential importance of persistent STAT activation in human tumorigenesis remains. Oncogene (2000).
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“IL-6 is also a key factor in inflammation, autoimmunity and cancer, with its effect mainly exerted through the IL-6–signal transducer and activator of transcription 3 (STAT3) pathway (18–26, 61–65).”
From IL-6 in inflammation, autoimmunity and cancer (2021) · cites this paper as [61]
In the citing paper
“HCV core protein interacts with the signal transducer and activator of transcription 3 (STAT3) protein36, a transcription factor involved in mediating cytokine signalling37.”
From Inflammation and cancer (2002) · cites this paper as [37]
Citations
Cites
Darnell, J. E., Kerr, L. M., & Stark, G. R. (1994) · Science · doi:10.1126/science.8197455 · Cited by 6,080
Darnell, J. E. (1997) · Science · doi:10.1126/science.277.5332.1630 · Cited by 3,979
HOW CELLS RESPOND TO INTERFERONS
Stark, G. R., Kerr, I. M., Williams, B. R. G., Silverman, R. H., & Schreiber, R. D. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.227 · Cited by 3,932
Virus interference. I. the interferon
Isaacs, A., & Lindenmann, J. (1957) · Proceedings of the Royal Society of London. Series B - Biological Sciences · doi:10.1098/rspb.1957.0048 · Cited by 3,451
Bromberg, J. F., Wrzeszczynska, M. H., Devgan, G., Zhao, Y., Pestell, R. G., Albanese, C., & Darnell, J. E. (1999) · Cell · doi:10.1016/s0092-8674(00)81959-5 · Cited by 2,790
Self-citationWen, Z., Zhong, Z., & Darnell, J. E. (1995) · Cell · doi:10.1016/0092-8674(95)90311-9 · Cited by 1,974
Meraz, M. A., White, J. M., Sheehan, K. C. F., Bach, E. A., Rodig, S. J., Dighe, A. S., Kaplan, D. H., Riley, J. K., Greenlund, A. C., Campbell, D., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81288-x · Cited by 1,656
Targeted Disruption of the Mouse Stat1 Gene Results in Compromised Innate Immunity to Viral Disease
Durbin, J. E., Hackenmiller, R., Simon, M. C., & Levy, D. E. (1996) · Cell · doi:10.1016/s0092-8674(00)81289-1 · Cited by 1,539
A Matter of Life and Cell Death
Evan, G. I., & Littlewood, T. D. (1998) · Science · doi:10.1126/science.281.5381.1317 · Cited by 1,528
Demonstration of an interferon γ-dependent tumor surveillance system in immunocompetent mice
Kaplan, D. H., Shankaran, V., Dighe, A. S., Stockert, E., Aguet, M., Old, L. J., & Schreiber, R. D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.13.7556 · Cited by 1,465
Flagged first, then by citations
Cited by
Sorted by citations
Items 601–700 of 1,000
Jak1 deficiency leads to enhanced Abelson-induced B-cell tumor formation
Sexl, V., Kovačic, B., Piekorz, R. P., Moriggl, R., Stoiber, D., Hoffmeyer, A., Liebminger, R., Kudlacek, O., Weisz, E., Rothammer, K., et al. (2003) · Blood · doi:10.1182/blood-2001-11-0142 · Cited by 37
Auzenne, E. J., Klostergaard, J., Mandal, P. K., Liao, W. S. ‐., Lü, Z., Gao, F., Bast, R. C., Robertson, F. M., & McMurray, J. S. (2012) · PubMed · Cited by 36
Phillips, T. M., & Smith, P. (2003) · Biomedical Chromatography · doi:10.1002/bmc.240 · Cited by 36
Kang, H. J., Yi, Y. W., Hou, S., Kim, H. J., Kong, Y., Bae, I., & Brown, M. L. (2015) · Oncotarget · doi:10.18632/oncotarget.4054 · Cited by 36
Thyrell, L., Arulampalam, V., Hjortsberg, L., Farnebo, M., Grandér, D., & Tamm, K. P. (2007) · Experimental Cell Research · doi:10.1016/j.yexcr.2007.08.007 · Cited by 37
GSTP1 negatively regulates Stat3 activation in epidermal growth factor signaling
Kou, X., Chen, N., Feng, Z., Luo, L., & Yin, Z. (2012) · Oncology Letters · doi:10.3892/ol.2012.1098 · Cited by 36
Tumang, J. R., Hsia, C. Y., Tian, W., Bromberg, J., & Liou, H. (2002) · Cellular Immunology · doi:10.1016/s0008-8749(02)00513-0 · Cited by 35
Self-citationLiu, T., & Ogle, T. F. (2002) · Biology of Reproduction · doi:10.1095/biolreprod67.1.114 · Cited by 35
hCAF1/CNOT7 regulates interferon signalling by targeting STAT1
Chapat, C., Kolytcheff, C., Romancer, M. L., Auboeuf, D., de la Grange, P., Chettab, K., Sentis, S., & Corbo, L. (2013) · The EMBO Journal · doi:10.1038/emboj.2013.11 · Cited by 35
Kim, E. O., Kang, S. E., Im, C. R., Lee, J., Ahn, K. S., Yang, W. M., Um, J., Lee, S., & Yun, M. (2016) · International Journal of Oncology · doi:10.3892/ijo.2016.3441 · Cited by 36
Mutational analysis reveals separable DNA binding and trans-activation of Drosophila STAT92E
Karsten, P., Plischke, I., Perrimon, N., & Zeidler, M. P. (2005) · Cellular Signalling · doi:10.1016/j.cellsig.2005.07.006 · Cited by 35
Mohankumar, K. M., Perry, J. K., Kannan, N., Kohno, K., Gluckman, P. D., Emerald, B. S., & Lobie, P. E. (2008) · Endocrinology · doi:10.1210/en.2007-1320 · Cited by 35
Feys, T., Poppe, B. G., Preter, K. D., Roy, N. V., Verhasselt, B., Paepe, P. D., Paepe, A. D., & Speleman, F. (2007) · Haematologica · doi:10.3324/haematol.11073 · Cited by 35
Zheng, Y., Wang, J., Meng, L., Pei, X., Zhang, L., An, L., Li, C., & Miao, Y. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112934 · Cited by 35
Zhang, Y., Ren, H., Li, J., Xue, R., Liu, H., Zhu, Z., Pan, C.-Y., Lin, Y., Hu, A., Gou, P., et al. (2021) · PubMed Central · Cited by 34
Sun, X., Wu, S., & Xing, D. (2010) · FEBS Journal · doi:10.1111/j.1742-4658.2010.07884.x · Cited by 34
Cuesta, N., Nhu, Q. M., Zudaire, E., Polumuri, S. K., Cuttitta, F. F., & Vogel, S. N. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.6.3602 · Cited by 36
Structural basis for the binding of high affinity phosphopeptides to Stat3
McMurray, J. S. (2007) · Biopolymers · doi:10.1002/bip.20901 · Cited by 35
STAT-3 activity in chemically-induced hepatocellular carcinoma
Sánchez, A., Nagy, P., & Thorgeirsson, S. S. (2003) · European Journal of Cancer · doi:10.1016/s0959-8049(03)00393-9 · Cited by 34
KPNB1-mediated nuclear import in cancer
Shi, Q., Lin, M., Cheng, X., Zhang, Z., Deng, S., Lang, K., Yang, Z., & Sun, X. (2023) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2023.175925 · Cited by 33
STAT3 Regulation of Citrate Synthase Is Essential during the Initiation of Lymphocyte Cell Growth
MacPherson, S., Horkoff, M. J., Gravel, C., Hoffmann, T., Zuber, J. A., & Lum, J. J. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.04.012 · Cited by 33
Amano, R., Yamashita, A., Kasai, H., Hori, T., Miyasato, S., Saito, S., Yokoe, H., Takahashi, K., Tanaka, T., Otoguro, T., et al. (2017) · Antiviral Research · doi:10.1016/j.antiviral.2017.07.018 · Cited by 33
Budi, H. S., Izadi, S., Timoshin, A., Asl, S. H., Beyzai, B., Ghaderpour, A., Alian, F., Eshaghi, F. S., Mousavi, S. M., Rafiee, B., et al. (2021) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2021.102373 · Cited by 33
Ni, J., Shen, Y., Wang, Z., Shao, D., Liu, J., Fu, L., Kong, Y.-L., Zhou, L., Xue, H., Huang, Y., et al. (2014) · Acta Pharmacologica Sinica · doi:10.1038/aps.2014.42 · Cited by 34
Park, E., Kang, J.-H., Seo, J. S., Kim, G., Chung, J., & Choi, T. (2008) · BMC Immunology · doi:10.1186/1471-2172-9-31 · Cited by 33
D’Cruz, O. J., Vassilev, A. O., & Uckun, F. M. (2001) · Fertility and Sterility · doi:10.1016/s0015-0282(01)01896-9 · Cited by 33
Liu, M., Leibowitz, J. L., Clark, D. A., Mendicino, M., Ning, Q., Ding, J. W., D'Abreo, C., Fung, L. S., Marsden, P. A., & Levy, G. A. (2003) · European Journal of Biochemistry · doi:10.1046/j.1432-1033.2003.03595.x · Cited by 33
Chen, Q., Ma, Y., & Ross, A. C. (2002) · Immunology · doi:10.1046/j.1365-2567.2002.01485.x · Cited by 34
Potential use of STAT3 inhibitors in targeted prostate cancer therapy: future prospects
Barton, B. E., & Barton, B. E. (2012) · OncoTargets and Therapy · doi:10.2147/ott.s32559 · Cited by 32
The metabolomic signature of hematologic malignancies
Allegra, A., Innao, V., Gerace, D. G., Bianco, O., & Musolino, C. (2016) · Leukemia Research · doi:10.1016/j.leukres.2016.08.002 · Cited by 32
A comprehensive review on anticancer mechanism of bazedoxifene
Zafar, E., Maqbool, M. F., Iqbal, A., Maryam, A., Shakir, H. A., Irfan, M. I., Khan, M. N., Li, Y., & Ma, T. (2021) · Biotechnology and Applied Biochemistry · doi:10.1002/bab.2150 · Cited by 33
Stojanovska, V., Arnold, S., Bauer, M., Voss, H., Fest, S., & Zenclussen, A. C. (2022) · Cells · doi:10.3390/cells11182884 · Cited by 32
Preclinical Therapeutic Potential of a Nitrosylating Agent in the Treatment of Ovarian Cancer
Giri, S., Rattan, R., Deshpande, M., Maguire, J. L., Johnson, Z., Graham, R. P., & Shridhar, V. (2014) · PLoS ONE · doi:10.1371/journal.pone.0097897 · Cited by 32
Ling, L., & Lobie, P. E. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m400601200 · Cited by 32
Fadlelmola, F. M., Zhou, M., de Leeuw, R. J., Dosanjh, N. S., Harmer, K., Huntsman, D. D., Lam, W. L., & Banerjee, D. (2008) · Molecular Cancer · doi:10.1186/1476-4598-7-2 · Cited by 32
Park, J., Strock, C. J., Ball, D. W., & Nelkin, B. D. (2004) · Cytokine · doi:10.1016/j.cyto.2004.10.005 · Cited by 32
Sferra (2011) · Molecular Medicine Reports · doi:10.3892/mmr.2011.413 · Cited by 32
Masciocchi, D., Villa, S., Meneghetti, F., Pedretti, A., Barlocco, D., Legnani, L., Toma, L., Kwon, B., Nakano, S., Asai, A., et al. (2012) · MedChemComm · doi:10.1039/c2md20018j · Cited by 32
Barton, B. E., Murphy, T. F., Adem, P. V., Watson, R. A., Irwin, R. J., & Huang, H. F. S. (2001) · BMC Cancer · doi:10.1186/1471-2407-1-19 · Cited by 32
Socs36E attenuates STAT signaling to optimize motile cell specification in the Drosophila ovary
Monahan, A., & Starz‐Gaiano, M. (2013) · Developmental Biology · doi:10.1016/j.ydbio.2013.03.022 · Cited by 34
Zhou, C., Huang, J., Chen, J., Lai, J., Zhu, F., Xu, X., & Wang, D. W. (2016) · Cellular Physiology and Biochemistry · doi:10.1159/000445663 · Cited by 32
Akiyama, Y., Nonomura, C., Ashizawa, T., Iizuka, A., Kondou, R., Miyata, H., Sugino, T., Mitsuya, K., Hayashi, N., Nakasu, Y., et al. (2017) · Immunology Letters · doi:10.1016/j.imlet.2017.07.005 · Cited by 32
Liu, Z., Wang, H., Guan, L., Lai, C., Yu, W., & Lai, M. (2019) · British Journal of Pharmacology · doi:10.1111/bph.14863 · Cited by 32
Kennedy, A. M., Shogren, K. L., Zhang, M., Turner, R. T., Spelsberg, T. C., & Maran, A. (2004) · Endocrinology · doi:10.1210/en.2004-0486 · Cited by 32
Dron, M., Meritet, J. F., Dandoy‐Dron, F., Meyniel, J.-P., Maury, C., & Tovey, M. G. (2002) · Genomics · doi:10.1006/geno.2002.6709 · Cited by 32
Skariah, N., James, O. J., & Swamy, M. (2024) · Discovery Immunology · doi:10.1093/discim/kyae002 · Cited by 31
Mechanisms and therapeutic prospect of the JAK-STAT signaling pathway in liver cancer
Jia, J., Zhou, X. J., & Chu, Q. (2024) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-024-04983-5 · Cited by 31
Long noncoding RNA PVT1 promotes hepatoblastoma cell proliferation through activating STAT3
Luo, Z., & Cao, P. (2019) · Cancer Management and Research · doi:10.2147/cmar.s213707 · Cited by 31
Kulesza, D. W., Carré, T., Chouaı̈b, S., & Kaminska, B. (2012) · Experimental Cell Research · doi:10.1016/j.yexcr.2012.11.005 · Cited by 31
Role of interleukin-6 in Barrett’s esophagus pathogenesis
Dvorak, K. (2013) · World Journal of Gastroenterology · doi:10.3748/wjg.v19.i15.2307 · Cited by 31
Chan, H. Y., Siu, M. K. Y., Zhang, H. J., Wong, E., Ngan, H., Chan, K. Y. K., & Cheung, A. (2008) · Histopathology · doi:10.1111/j.1365-2559.2008.03089.x · Cited by 31
Kim, H., Suh, J. M., Hwang, E. S., Kim, D. W., Chung, H. K., Song, J. H., Hwang, J. H., Park, K. C., Ro, H. K., Jo, E., et al. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.2.616 · Cited by 31
Mahboubi, K., & Pober, J. S. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m107542200 · Cited by 31
Namanja, A. T., Wang, J., Buettner, R., Colson, L., & Chen, Y. (2016) · Journal of Molecular Biology · doi:10.1016/j.jmb.2016.01.003 · Cited by 31
You, N., Liu, G., Yu, M., Chen, W., Fei, X., Sun, T., Han, M., Qin, Z., Wei, Z., & Wang, D. (2025) · Journal of Advanced Research · doi:10.1016/j.jare.2024.12.049 · Cited by 31
Lack of FSH support enhances LIF–STAT3 signaling in granulosa cells of atretic follicles in cattle
Ilha, G. F., Rovani, M. T., Gasperin, B. G., Antoniazzi, A. Q., Gonçalves, P. B. D., Bordignon, V., & Duggavathi, R. (2015) · Reproduction · doi:10.1530/rep-15-0026 · Cited by 30
Fang, S., Xu, H., Lu, J.-R., Zhu, Y., & Jiang, H. (2013) · Neurochemical Research · doi:10.1007/s11064-013-1139-4 · Cited by 30
Zhang, Z., Mao, H., Du, X., Zhu, J., Xu, Y., Wang, S., Xu, X., Ji, P., Yu, Y., Cao, B., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.6974 · Cited by 30
Jang, H., Ko, H., Song, K., & Kim, Y. S. (2019) · Biomolecules · doi:10.3390/biom9070278 · Cited by 30
Computational models of the JAK1/2-STAT1 signaling
Gambin, A., Charzyńska, A., Ellert‐Miklaszewska, A., & Rybiński, M. (2013) · JAK-STAT · doi:10.4161/jkst.24672 · Cited by 31
Veenbergen, S., Bennink, M. B., de Hooge, A. S. K., Arntz, O. J., Smeets, R. L., van den Berg, W. B., & van de Loo, F. A. J. (2008) · Arthritis & Rheumatism · doi:10.1002/art.24072 · Cited by 31
Höpfner, M., Sutter, A. P., Huether, A., Ahnert‐Hilger, G., & Scherübl, H. (2004) · BMC Cancer · doi:10.1186/1471-2407-4-23 · Cited by 30
Vaziri, Z., Saleki, K., Aram, C., Alijanizadeh, P., Pourahmad, R., Azadmehr, A., & Ziaei, N. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115686 · Cited by 31
IL-32θ downregulates CCL5 expression through its interaction with PKCδ and STAT3
Bak, Y., Kang, J.-W., Kim, M. S., Park, Y. S., Kwon, T., Kim, S., Hong, J. T., & Yoon, D. (2014) · Cellular Signalling · doi:10.1016/j.cellsig.2014.09.015 · Cited by 30
STAT signaling as a marker of SLE disease severity and implications for clinical therapy
Goropevšek, A., Holcar, M., Pahor, A., & Avčin, T. (2018) · Autoimmunity Reviews · doi:10.1016/j.autrev.2018.08.010 · Cited by 29
Zhang, X., Liu, P., Zhang, B., Mao, H., Shen, L., & Ma, Y. (2013) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2013.1431 · Cited by 29
The role of IL-21 in hematological malignancies
Ma, J., Ma, D., & Ji, C. (2011) · Cytokine · doi:10.1016/j.cyto.2011.07.011 · Cited by 29
Sorafenib induces apoptosis in HL60 cells by inhibiting Src kinase-mediated STAT3 phosphorylation
Zhao, W. M., Zhang, T., Qu, B., Wu, X., Zhu, X. C., Meng, F., Gu, Y., Shu, Y., Shen, Y., Sun, Y., et al. (2010) · Anti-Cancer Drugs · doi:10.1097/cad.0b013e32833f44fd · Cited by 29
Garg, S. M., Vakili, M. R., Molavi, O., & Lavasanifar, A. (2017) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.6b01119 · Cited by 30
Wu, A., Sciacca, L., & Baserga, R. (2003) · Journal of Cellular Physiology · doi:10.1002/jcp.10261 · Cited by 29
Zhukovskaya, N. V., Fukuzawa, M., Tsujioka, M., Jermyn, K. A., Kawata, T., Abe, T., Zvelebil, M., & Williams, J. G. (2003) · Development · doi:10.1242/dev.00927 · Cited by 29
Dormann, D., Abe, T., Weijer, C. J., & Williams, J. G. (2001) · Development · doi:10.1242/dev.128.7.1081 · Cited by 29
Lango, M. N., Shin, D. M., & Grandis, J. R. (2001) · Current Opinion in Oncology · doi:10.1097/00001622-200105000-00007 · Cited by 29
Singh, K., Piprode, V., Mhaske, S. T., Barhanpurkar, A. P., & Wani, M. R. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1601528 · Cited by 28
Araki, T., Langenick, J., Gamper, M., Firtel, R., & Williams, J. G. (2008) · Development · doi:10.1242/dev.009936 · Cited by 28
Breuck, S. D., Baeyens, L., & Bouwens, L. (2005) · Diabetologia · doi:10.1007/s00125-005-0079-1 · Cited by 28
MAPPIT: a cytokine receptor‐based two‐hybrid method in mammalian cells 1
Tavernier, J. H., Eyckerman, S., Lemmens, I. H., der Heyden, J. V., Vandekerckhove, J. S., & Ostade, X. V. (2002) · Clinical & Experimental Allergy · doi:10.1046/j.1365-2745.2002.01520.x · Cited by 28
Vanadium-induced STAT-1 activation in lung myofibroblasts requires H2O2 and P38 MAP kinase
Wang, Y.-Z., Ingram, J. L., Walters, D. M., Rice, A. B., Santos, J. H., Houten, B. V., & Bonner, J. C. (2003) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(03)00399-x · Cited by 28
Chelsky, Z. L., Yue, P., Kondratyuk, T. P., Paladino, D., Pezzuto, J. M., Cushman, M., & Turkson, J. (2015) · Molecular Pharmacology · doi:10.1124/mol.115.099093 · Cited by 28
Jiang, Q., Li, Q., Chen, H., Shen, A., Cai, Q., Lin, J., & Peng, J. (2015) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2015.2692 · Cited by 27
Gujam, F. J. A., McMillan, D. C., & Edwards, J. (2016) · Oncotarget · doi:10.18632/oncotarget.12730 · Cited by 27
Noman, M. A. A., Hossain, T., Ahsan, M., Jamshidi, S., Hasan, C. M., & Rahman, K. M. (2018) · Journal of Natural Products · doi:10.1021/acs.jnatprod.7b00377 · Cited by 27
Bt354 as a new STAT3 signaling pathway inhibitor against triple negative breast cancer
Chen, Y., Ji, M., Zhang, S., Xue, N., Xu, H., Lin, S., & Chen, X. (2018) · Journal of drug targeting · doi:10.1080/1061186x.2018.1452244 · Cited by 27
Chen, X., Zheng, Q., Li, W., Lu, Y. Q., Ni, Y., Ma, L., & Fu, Y. (2018) · OncoTargets and Therapy · doi:10.2147/ott.s176533 · Cited by 27
Kikuchi, H., Jung, H. J., Raghuram, V., Leo, K. T., Park, E., Yang, C., Chou, C.-L., Chen, L., & Knepper, M. A. (2021) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00204.2021 · Cited by 27
Combinatorial therapy for triple negative breast cancer using hyperstar polymer-based nanoparticles
Misra, S. K., Wang, X., Srivastava, I., Imgruet, M. K., Graff, R. W., Ohoka, A., Kampert, T. L., Gao, H., & Pan, D. (2015) · Chemical Communications · doi:10.1039/c5cc07709e · Cited by 27
Uluer, E. T., Aydemir, I., İnan, S., Özbilgin, K., & Vatansever, S. (2011) · Acta Histochemica · doi:10.1016/j.acthis.2011.11.010 · Cited by 27
Pang, X., Chen, S., Wang, X., & Zhong, L. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17081130 · Cited by 27
Defined Host–Guest Chemistry on Nanocarbon for Sustained Inhibition of Cancer
Ostadhossein, F., Misra, S. K., Mukherjee, P., Ostadhossein, A., Daza, E., Tiwari, S., Mittal, S., Gryka, M. C., Bhargava, R., & Pan, D. (2016) · Small · doi:10.1002/smll.201601161 · Cited by 27
Caveolin-2 regulation of STAT3 transcriptional activation in response to insulin
Kwon, H., Jeong, K., Hwang, E. M., Park, J., Hong, S.-G., Choi, W.-S., & Pak, Y. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2009.04.015 · Cited by 29
Cross-talk Between Retinoic Acid and STAT3 Signaling Pathways in Acute Promyelocytic Leukemia
Dong, S., Chen, S., & Tweardy, D. J. (2003) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/1042819031000116670 · Cited by 27
Involvement of c-Src/STAT3 signal in EGF-induced proliferation of rat spermatogonial stem cells
Chen, J., Xu, L., Wang, X.-C., Qin, H.-Y., & Wang, J. (2011) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-011-0922-2 · Cited by 27
Ji, P., Xu, X., Ma, S., Fan, J., Zhou, Q., Mao, X., & Qiao, C. (2015) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.5b00228 · Cited by 27
Lin, W., Dai, W., Xu, X., Yu, Q., Zhang, B., Li, J., & Li, H. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.04.170 · Cited by 26
WNT2-Mediated FZD2 Stabilization Regulates Esophageal Cancer Metastasis via STAT3 Signaling
Fu, Y., Zheng, Q., Mao, Y., Jiang, X., Chen, X., Liu, P., Lv, B., Huang, T., Yang, J., Cheng, Y., et al. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.01168 · Cited by 26
Exosomes and MicroRNAs in Biomedical Science
Mirzaei, H., Rahimian, N., Mirzaei, H. R., Nahand, J. S., & Hamblin, M. R. (2022) · Synthesis lectures on biomedical engineering · doi:10.2200/s01171ed1v01y202202bme062 · Cited by 27
Immunotherapy as part of a multidisciplinary approach to melanoma treatment
Adam, I. R. (2006) · Frontiers in bioscience · doi:10.2741/1775 · Cited by 26
An RNA biding protein, Y14 interacts with and modulates STAT3 activation
Ohbayashi, N., Taira, N., Kawakami, S., Togi, S., Sato, N., Ikeda, O., Kamitani, S., Muromoto, R., Sekine, Y., & Matsuda, T. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.05.073 · Cited by 26
Khan, A. I., Kapoor, A., Chen, J., Märtin, L., Rogazzo, M., Mercier, T., Decosterd, L. A., Collino, M., & Thiemermann, C. (2017) · Shock · doi:10.1097/shk.0000000000000963 · Cited by 26
Gao, Y., Basile, J. I., Classon, C., Gavier‐Widén, D., Yoshimura, A., Carow, B., & Rottenberg, M. E. (2018) · PLoS Pathogens · doi:10.1371/journal.ppat.1006809 · Cited by 26
Metadata
- Authors
- Bromberg, J., & Darnell, J. E.
- Affiliations
- Rockefeller University (US)
- ORCID
- Bromberg, Jacqueline
- Venue
- Oncogene
- Published
- 2000-05-25
- Volume
- 19
- Issue
- 21
- Pages
- 2468-2473
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W1977681992
- Cited by
- 1,201
- References
- 66
- Citations by year
- 2026: 10 · 2025: 22 · 2024: 21 · 2023: 24 · 2022: 37 · 2021: 40 · 2020: 46 · 2019: 41 · 2018: 42 · 2017: 51 · 2016: 46 · 2015: 49 · 2014: 59 · 2013: 67 · 2012: 56
- FWCI
- 6.32
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Oncogene (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Tyrosine Phosphatases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Keywords
- STAT proteins, transcriptional regulation, cytokine signaling, JAK kinases, tyrosine phosphorylation, STAT1, STAT3, STAT5, cell cycle progression, apoptosis, tumor suppressor, cell transformation, carcinogenesis, transcriptional coactivator
- MeSH terms
- Animals, Cell Division, Cell Transformation, Neoplastic, DNA-Binding Proteins, Gene Expression Regulation, Humans, Milk Proteins, Neoplasms, Structure-Activity Relationship, Transcription, Genetic, Trans-Activators, STAT1 Transcription Factor, STAT3 Transcription Factor, STAT5 Transcription Factor
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review